Hakeemah H Alnakhle

11PUBLICATIONS
10CO-AUTHORS
Molecular targetsEpigenetics (incl. genome methylation and epigenomics)Cancer geneticsPredictive and prognostic markersNanotoxicology, health and safety
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Aug 27, 2026
Tumor-Intrinsic DNA Damage Signaling Is Associated with MHC-I Expression and CD8 Cytotoxic T-Cell Engagement in Triple-Negative Breast Cancer.

|Aug 13, 2026
Integrative Clinical and Functional Characterization of the TCF7L2 rs7903146 Variant Reveals Regulatory Mechanisms Linking Genetic Susceptibility to Oxidative Stress in Type 2 Diabetes.

|Jul 28, 2026
Integrative Single-Cell and Bulk Transcriptomic Analyses with Spatial Validation Identify a Residual Fatty Acid-EMT Subset Driving Chemotherapy Resistance in Triple-Negative Breast Cancer via MIF- and MK-Mediated Ligand-Receptor Signaling.

|Oct 29, 2025
In Silico Characterization of Pathogenic ESR2 Coding and UTR Variants as Oncogenic Potential Biomarkers in Hormone-Dependent Cancers.

Hakeemah Al-Nakhle, Zainab Almoerifi, Layan Alharbi

|Mar 28, 2025
Integrative In Silico Analysis to Identify Functional and Structural Impacts of nsSNPs on Programmed Cell Death Protein 1 (PD-1) Protein and UTRs: Potential Biomarkers for Cancer Susceptibility.

Hakeemah Al-Nakhle, Retaj Al-Shahrani, Jawanah Al-Ahmadi

|Oct 15, 2024
Elucidating the role of MLL1 nsSNPs: Structural and functional alterations and their contribution to leukemia development.

Hakeemah H Al-Nakhle, Hind S Yagoub, Rahaf Y Alrehaili

Pageof 2

Frequent Collaborators

2 joint publications

Zinab O Doha

1 joint publications

Aiah M Khateb

1 joint publications

Ahmed M Ahmed

1 joint publications

Amjad M Yousuf